Dr. McGrew is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8060 Wolf River Blvd
Memphis, TN 38138Phone+1 901-271-1000Fax+1 901-271-2161
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 1974 - 1976
- Duke University HospitalResidency, Internal Medicine, 1973 - 1974
- Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 1970 - 1971
- Case Western Reserve University School of MedicineClass of 1970
Certifications & Licensure
- MS State Medical License 1991 - 2025
- TN State Medical License 1976 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Start of enrollment: 2010 Apr 01
- Ranolazine Implantable Cardioverter-Defibrillator Trial Start of enrollment: 2011 Sep 01
- Respicardia, Inc. Pivotal Trial of the remedē System Start of enrollment: 2013 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 407 citationsA Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart FailureJay N. Cohn, Sidney Goldstein, Barry H. Greenberg, Beverly H. Lorell, Robert C. Bourge
The New England Journal of Medicine. 1998-12-17 - 481 citationsEffects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized with Worsening Heart Failure: A Randomized Controlled TrialMihai Gheorghiade, Wendy A. Gattis, Christopher M. O'Connor, Kirkwood F. Adams, Uri Elkayam
JAMA. 2004-04-28 - 40 citationsLeadless left ventricular stimulation with WiSE-CRT System - Initial experience and results from phase I of SOLVE-CRT Study (nonrandomized, roll-in phase).Toshimasa Okabe, John D. Hummel, Alan J. Bank, Imran Niazi, Frank McGrew
Heart Rhythm. 2021-07-23
Press Mentions
- New Study Shows Drug Could Lower Risk of Heart Attack in People with High TriglyceridesNovember 30th, 2018
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: